KRAS and neoplasm: When the expression intensity and the cellular distribution of TRAIL-receptors on tumor samples were analyzed in relation to different clinico-pathological variables including KRAS-mutation status and the presence of microsatellite instability, no correlation could be detected as judged by Fisher's exact test (Tables S1 and S2).